Buscar
01/06/2024
Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
Garassino, MC, Wakelee, HA, Spicer, J, Liberman, M, Kato, T, Tsuboi, M, Lee, SH, Chen, KN, Dooms, CA, Majem, M, Eigendorff, E, Martinengo, GL, Bylicki, O, Rodriguez-Abreu, D, Chaft, JE, Yang, J, Arunachalam, A, Norquist, JM, Keller, SM, Gao, SG. Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024
Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study
Soler, RS, Vivas, CS, Macias, I, Esteban, AY, Bassam, A, Plazas, JG, Al-Farhat, Y, Cervantes, A, Alfonso, PG, Paez, D, Ruiz-Casado, A, Lopez, C, Arkosy, PF, Furka, A, Rodriguez-Salas, N, Pascual, FJR, Gracian, AC, Hitre, E, Monteagudo, RF, Salvia, MAS. Positive ad hoc results from neoadjuvant Foxy-5 treatment of colon cancer patients in the ongoing phase II NeoFox study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.020. PMID:. IF:65.400(Q1/1D).
01/06/2024
Be aware of the X: BCOR mutations in myeloid neoplasms
Ramil, G, Pratcorona, M, Nomdedéu, JF. Be aware of the X: BCOR mutations in myeloid neoplasms. HAEMATOLOGICA. 2024; 109(6)DOI:10.3324/haematol.2023.284748. PMID:38328862. IF:10.100(Q1/2D).
01/06/2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas
Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).
01/06/2024
Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis
Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).
01/06/2024
Lacrimal duct Surgery: Different Techniques and Long-Term Postoperative Results
Casasayas, M, Massegur-Solench, H, Martel-Marín, M, Kolanczak, KA, Holgado, A, Gras-Cabrerizo, JR. Lacrimal duct Surgery: Different Techniques and Long-Term Postoperative Results. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024; DOI:10.1007/s12070-024-04670-3. PMID:39376430. IF:0.054(Q4/10D).
01/06/2024
Allergy to Theobroma Cacao
Valencia, AN, Retes, LS, Bartolomé-Zavala, B, Gutiérrez, GP, Bigorra, T. Allergy to Theobroma Cacao. Clinical Case Reports. 2024; 12(6)DOI:10.1002/ccr3.8803. PMID:38883222. IF:(Q/D).
01/06/2024
Changes in prevalence and socioeconomic inequalities in secondhand smoke exposure in Spanish children, 2016-2019
Sanz-Mas, M, Continente, X, Henderson, E, Fernández, E, Schiaffino, A, Pérez-Ríos, M, Espelt, A, Guxens, M, López, MJ. Changes in prevalence and socioeconomic inequalities in secondhand smoke exposure in Spanish children, 2016-2019. Tobacco Induced Diseases. 2024; 22DOI:10.18332/tid/189392. PMID:38910916. IF:1.900(Q3/6D).